e-learning
resources
Vienna 2003
Monday 29.09.2003
Glucocorticosteroids: an update on their use
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of the effect of short course of oral prednisone in patients with moderate and severe persistent asthma
E. Razi, G. Moosavi (Kashan, Iran)
Source:
Annual Congress 2003 - Glucocorticosteroids: an update on their use
Session:
Glucocorticosteroids: an update on their use
Session type:
Thematic Poster Session
Number:
1824
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Razi, G. Moosavi (Kashan, Iran). Comparison of the effect of short course of oral prednisone in patients with moderate and severe persistent asthma. Eur Respir J 2003; 22: Suppl. 45, 1824
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Patterns of resolution of acute severe asthma in children when treated with oral prednisolone
Source: Eur Respir J 2001; 18: Suppl. 33, 122s
Year: 2001
The effect of long-term treatment with erdosteine on moderate or severe COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Patients with moderate asthma symptoms may benefit from short-term inhaled corticosteroid monotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 615s
Year: 2007
Comparison of the efficacy of cicleosonide with budesonide in mild to moderate asthma patients after step-down therapy
Source: Annual Congress 2011 - Asthma management and response
Year: 2011
Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020
Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers
Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways
Year: 2003
Efficacy and safety of single doses of inhaled LAS100977 in patients with mild to moderate asthma
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010
Therapeutic effect of low dose roxithromycin in chronic stable mild-to-moderate asthma
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
The oral corticosteroid sparing effect of omalizumab in patients with severe chronic asthma: Is there a difference when you become 12 years old?
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011
Efficacy of short-term high dose predonisolone therapy in acute exacerbation of bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 71s
Year: 2001
Effects of exercise in patients with moderate to severe asthma
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
Source: International Congress 2017 – Asthma management
Year: 2017
Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV
1
in patients with severe persistent allergic asthma irrespective of age
Source: Eur Respir J 2005; 26: Suppl. 49, 48s
Year: 2005
Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 379s
Year: 2004
Evaluating the efficacy of omalizumab in severe persistent asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept